Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-28T15:41:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T20:34:46.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T20:21:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:44:12.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating access is denied to the record. Several key study documents and related links were removed from the page, reducing publicly available information about the trial.
    Difference
    16%
    Check dated 2026-09-23T21:50:50.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A new page revision identifier v3.7.0 has been added, replacing the previous v3.6.6. This appears to be a technical/metadata update to the page rather than a change to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-16T21:41:07.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.